The First Fungal Identification from Mini-BAL of Critical COVID-19 Patients
Archives of Pediatric Infectious Diseases · 2023
DOI: 10.5812/apid-136153 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Pediatric Infectious Diseases, 2023. Verfasst von Fatemeh Fallah und 9 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Coronavirus disease 2019 (COVID-19) has become a worldwide issue due to its high prevalence and rapid transmission. Fungal infections have been detected in COVID-19 patients, leading to increased morbidity and mortality.
Objectives
This study aimed to isolate Aspergillus fumigatus and Mucor spp. on mini-bronchoalveolar lavage samples obtained from children with COVID-19 hospitalized in an Iranian children's hospital.
Methods
A cross-sectional descriptive study was performed on mini-bronchoalveolar lavage samples from children confirmed positive for COVID-19 admitted to ICU with a ventilator from April 2021 to February 2022. Demographic characteristics were recorded, and fungal DNA was extracted from mini-BAL samples taken from children. Nested PCR was made with two primers for Aspergillus fumigatus and Mucor spp.
Results
Out of 100 children with COVID-19, all samples were negative for Aspergillus fumigatus; however, 12 cases were positive for BAL PCR for Mucor spp. Among the 12 patients, fever, shortness of breath, cough, and decreased level of consciousness were reported in 8.3% (n: 1), 16.6% (n: 2), 25% (n: 3), and 25% (n: 3), respectively. Most cases (41.7%; n: 5) suffered from heart disease, followed by underlying malignancy (33.4%; n: 4). All positive BAL PCR for Mucor spp. cases had significantly higher chest CT scan scores and spent more time under a ventilator.
Conclusions
The identification of COVID-19 with Mucor spp. was observed among 12% (n: 12) of children hospitalized in a COVID-19 ICU. When dealing with pediatric COVID-19 patients, clinicians should consider the differential diagnosis of fungal co-infections and have a low threshold to begin treatment. Moreover, it is highly advisable to take prophylactic measures, such as properly using corticosteroids and shortening the intubation time.
Zitieren
APA
Fallah, F., Lotfali, E., Azimi, L., Khodaei, H., Rajabnejad, M., Abdollahi, N., Tayebi, H., Ansari, S., Yaghoubi, S., & Karimi, A. (2023). The First Fungal Identification from Mini-BAL of Critical COVID-19 Patients. Archives of Pediatric Infectious Diseases. https://doi.org/10.5812/apid-136153
Vancouver
Fallah F, Lotfali E, Azimi L, Khodaei H, Rajabnejad M, Abdollahi N, et al. The First Fungal Identification from Mini-BAL of Critical COVID-19 Patients. Archives of Pediatric Infectious Diseases. 2023. doi:10.5812/apid-136153
BibTeX
@article{Fallah2023,
author = {Fallah, Fatemeh and Lotfali, Ensieh and Azimi, Leila and Khodaei, Hannan and Rajabnejad, Maryam and Abdollahi, Nafiseh and Tayebi, Hossein and Ansari, Saham and Yaghoubi, Saeedeh and Karimi, Abdollah},
title = {The First Fungal Identification from Mini-BAL of Critical COVID-19 Patients},
journal = {Archives of Pediatric Infectious Diseases},
year = {2023},
doi = {10.5812/apid-136153}
}
EUVIMED